ADSTILADRIN

Serial Number 98445129
Registration 7693470
700

Registration Progress

Application Filed
Mar 12, 2024
Under Examination
Approved for Publication
Dec 31, 2024
Published for Opposition
Dec 31, 2024
Registered
Feb 18, 2025

Trademark Image

ADSTILADRIN

Basic Information

Serial Number
98445129
Registration Number
7693470
Filing Date
March 12, 2024
Registration Date
February 18, 2025
Published for Opposition
December 31, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 18, 2025
Registration
Registered
Classes
042 044

Rights Holder

Ferring B.V.

16
Address
Polarisavenue 144
Hoofddorp 2132 JX
NL

Ownership History

Ferring B.V.

Original Applicant
16
Hoofddorp NL

Ferring B.V.

Owner at Publication
16
Hoofddorp NL

Ferring B.V.

Original Registrant
16
Hoofddorp NL

Legal Representation

Attorney
Joyce M. Ferraro

USPTO Deadlines

Next Deadline
2040 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-18)
Due Date
February 18, 2031
Grace Period Ends
August 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Feb 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 31, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 9, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 9, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 9, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 9, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 9, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 31, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 31, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 31, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 9, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 9, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 9, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 1, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 1, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 1, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jul 1, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jul 1, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 1, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing information about medical research
First Use Anywhere: 20230900
First Use in Commerce: 20230900
Class 044
Providing health and medical information
First Use Anywhere: 20230900
First Use in Commerce: 20230900

Additional Information

Design Mark
The mark consists of the stylized wording "ADSTILADRIN". Four stylized arrows arranged in a semicircle and pointing inwards appear to the left of the first "A".

Classification

International Classes
042 044